Ghogawala Z, Choi E, Daly K R, Blanco L R, Griffith I J, Glimcher L H
Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts.
Mol Cell Biol. 1989 Oct;9(10):4402-8. doi: 10.1128/mcb.9.10.4402-4408.1989.
Several biologically important examples of posttranscriptionally regulated genes have recently been described (T. Gerster, D. Picard, and W. Schaffner, Cell 45:45-52, 1986; R. Reeves, T.S. Elton, M.S. Nissen, D. Lehn, and K.R. Johnson, Proc. Natl. Acad. Sci. USA 84:6531-6535, 1987; H.A. Young, L. Varesio, and P. Hwu, Mol. Cell. Biol. 6:2253-2256, 1986). Little is known, however, regarding sequences that mediate posttranscriptional RNA stability. Characterization in our laboratory of a mutant murine B lymphoma, M12.C3, revealed a posttranscriptional defect affecting the synthesis of a major histocompatibility complex class II gene (A beta d) whose product normally controls both the specificity and magnitude of the immune response. Molecular studies revealed that the mutation responsible for diminished A beta d gene expression was an intronic deletion of 10 base pairs (bp) located 99 bp 5' of the third exon. This deletion lies in a region not known to be critical for accurate and efficient splicing. Furthermore, sequence analysis of amplified A beta-specific cDNA demonstrated that the small number of A beta d transcripts produced in the mutant cells was correctly spliced. It appears that the mechanism by which this intronic 10-bp deletion acts to decrease RNA stability is unlikely to be at the level of RNA splicing.
最近已经描述了几个转录后调控基因的重要生物学实例(T. 格斯特、D. 皮卡德和W. 沙夫纳,《细胞》45:45 - 52,1986;R. 里夫斯、T.S. 埃尔顿、M.S. 尼森、D. 莱恩和K.R. 约翰逊,《美国国家科学院院刊》84:6531 - 6535,1987;H.A. 扬、L. 瓦雷西奥和P. 胡,《分子与细胞生物学》6:2253 - 2256,1986)。然而,关于介导转录后RNA稳定性的序列却知之甚少。我们实验室对一种突变的小鼠B淋巴瘤M12.C3进行的特征分析揭示了一种转录后缺陷,该缺陷影响主要组织相容性复合体II类基因(Aβd)的合成,其产物通常控制免疫反应的特异性和强度。分子研究表明,导致Aβd基因表达减少的突变是位于第三个外显子5'端99个碱基对处的10个碱基对(bp)的内含子缺失。该缺失位于一个对于准确高效剪接并非关键的区域。此外,对扩增的Aβ特异性cDNA的序列分析表明,突变细胞中产生的少量Aβd转录本被正确剪接。看来这种内含子10 - bp缺失降低RNA稳定性的机制不太可能发生在RNA剪接水平。